| Structure |
Chemical Name |
CAS |
MF |
![2-[(4-Chloro-3-Methyl-2-Pyridinyl-methyl)thio]-1H-Benzimidazole](/CAS/GIF/103312-62-5.gif) |
2-[(4-Chloro-3-Methyl-2-Pyridinyl-methyl)thio]-1H-Benzimidazole |
103312-62-5 |
C14H12ClN3S |
 |
Pazufloxacin |
127046-18-8 |
C18H19FN2O4 |
 |
Vinpocetine |
80038-06-8 |
C22H26N2O2 |
 |
7-(but-2-yn-1-yl)-8-(3-(hydroxyimino)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione |
1297273-94-9 |
|
 |
Isavuconazole Impurity 35 |
|
|
 |
Brivaracetam Impurity 26 HCl |
|
|
 |
Brivaracet amoxidation Impurity 1 |
|
|
 |
Rosuvastatin EP Impurity G Complete Set |
|
|
 |
Bortezomib Impurity G Complete Set |
|
|
 |
Peramivir Diacetyl Impurity |
|
|
 |
Peramivir Chlorisomeric Impurity |
|
|
 |
Canagliflozin impurities 15 drops |
|
|
 |
Pemetrexed Impurities 41-45 |
|
|
 |
Pemetrexed Disodium EP Impurity 999 |
|
|
 |
Bumetanide Impurity 999 |
|
|
 |
Canagliflozin Impurity 998 |
|
|
 |
N,N-dimethyl-1,4,8,11-tetraazacyclotetradecane-1-sulfonamide |
|
|
![(41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid](/CAS/20211123/GIF/59413-21-7.gif) |
(41S,12S,13aS)-13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylic acid |
59413-21-7 |
C20H25N2NaO3 |
 |
BDJS-SH 1 |
36588-45-1 |
C12H18N2O2 |
 |
Acyclovir Impurity O |
|
|
 |
Alogliptin Impurity 19 |
|
|
 |
Alogliptin Impurity 19 |
|
|
 |
Aprepitant Impurity 17 |
1333998-27-8 |
C20H19ClF7NO2 |
 |
Blonanserin impurity A |
|
|
 |
Captopril impurity 2 |
|
|
 |
Ciprofloxacin Impurity D HCl |
526204-10-4 |
C17H18FN3O3 |
 |
Clindamycin Impurity 6 |
|
|
 |
Dabigatran Impurity 5 |
|
|
 |
DecitaBine Impurity 10 |
|
|
 |
Empagliflozin Impurity 17 |
2452301-27-6 |
C23H28O7 |
 |
Erlotinib Impurity 31 |
|
|
 |
Everolimus impurity C |
|
|
 |
Ezetimibe Impurity 28 |
|
|
 |
FeBuxostat Impurity 30 |
|
|
 |
Fluconazole Impurity 5 |
94952-36-0 |
C14H14F2N6O |
 |
Fosaprepitant Impurity 2 |
|
|
 |
Imidafenacin Impurity 4 |
503598-78-5 |
C16H18N2O |
 |
Intedanib Impurity H |
|
|
 |
Isavuconazole Impurity 16 |
|
|
 |
Isavuconazole Impurity 4 |
|
|
 |
Lenvatinib Impurity 4 |
|
C28H22ClN5O5 |
 |
Linagliptin Impurity 45 |
|
|
 |
MiraBegron Impurity F |
|
|
 |
Moxifloxacin Impurity 19 |
|
|
 |
Moxifloxacin Impurity 34 |
1824286-08-9 |
C9H7ClF2O3 |
 |
Nifedipine Impurity J |
114709-68-1 |
C16H17N3O5 |
 |
Oxiracetam Impurity I |
142274-07-5 |
C7H9NO4 |
 |
PalBociclib Impurity 4 |
|
|
 |
Plerixafor Impurity 4 |
|
|
 |
Posaconazole Impurity 29 |
|
|
 |
Posaconazole Impurity 34 |
|
|
 |
Posaconazole Impurity 58 |
|
|
 |
Pregabalin Impurity 4 |
1955498-14-2 |
C10H22ClNO2 |
 |
Rabeprazole Impurity 17 |
|
|
 |
Diltiazem impurity |
115992-91-1 |
C17H18N2O3S |
 |
Raloxifene EP IMpurity |
1700655-64-6 |
C13H15ClN2O2S |
 |
Parecoxib Impurity M |
|
|
![Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro-](/CAS/20200119/GIF/1648791-23-4.gif) |
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-[4-(4-ethyl-1-piperazinyl)phenyl]-5,6,7,8,9,10-hexahydro- |
1648791-23-4 |
C29H43N5 |
 |
Linagliptin Impurity O |
|
|
 |
Linagliptin Impurity T |
|
|
 |
SofosBuvir Impurity 14 |
|
|
 |
sofosBuvir Impurity 34 |
|
|
 |
SofosBuvir Impurity 50 |
|
|
 |
SofosBuvir Impurity 56 |
|
|
 |
Tofacitinib impurity T |
1092578-43-2 |
C16H20N6O |
 |
Valsartan Impurity 39 |
|
C24H29N5O3 |
 |
(1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)cyclopropanecarboxylic acid |
1369769-35-6 |
C17H17FN2O3 |
 |
Donepezil Impurity |
844694-84-4 |
C24H31NO2 |
 |
imp.E |
950781-89-2 |
C13H12F3N3O3 |
 |
Lidocaine EP Impurity |
31785-64-5 |
C12H18N2O.ClH |
 |
Prucalopride Impurity 1 |
1900715-96-9 |
C18H24ClN3O3 |
 |
3-(5-CHLOROPYRID-2-YL)CARBAMOYLPYRAZINE-2-CARBOXYLIC ACID(WXG01564) |
43200-83-5 |
C11H7ClN4O3 |
 |
Ampicillin Impurity Q |
|
|
 |
Cefdinir Impurity PQ(CP) |
|
|
 |
Cefdinir Impurity IJKL |
|
|
 |
Ceftazidime Impurity A (EP) |
|
|
 |
Oxacillin Sodium Impurity E(EP) |
|
|
 |
Spectinomycin Impurity B |
|
|
 |
Eriodictyol-8-glucoside |
153733-96-1 |
C21H22O11 |
 |
Naringin 4'-glucoside |
17257-21-5 |
C33H42O19 |
![8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride](/CAS/20180528/GIF/2143944-64-1.gif) |
8-(benzo[b]thiophen-4-yl)-5,8-diazaspiro[4.5]decan-5-ium chloride |
2143944-64-1 |
C16H21N2S+ |
![2-(4'-chloro-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-yl)-3-hydroxynaphthalene-1,4-dione](/CAS/20180528/GIF/1809464-27-4.gif) |
2-(4'-chloro-2,3,4,5-tetrahydro-[1,1'-biphenyl]-4-yl)-3-hydroxynaphthalene-1,4-dione |
1809464-27-4 |
C22H17ClO3 |
 |
Aprepitant impurity C |
|
|
 |
Ticagrelor Related Compound 14 |
2056269-94-2 |
C23H28F2N6O4S |
 |
Cefoxitin impurity E |
2395025-32-6 |
C17H19N3O8S2 |
 |
N-((4-(3-methyl-5-phenylisoxazol-4-yl)phenyl)sulfonyl)propionamide |
477594-28-8 |
C19H18N2O4S |
 |
Moxifloxacin EP Impurity D HCl |
|
|
 |
Moxifloxacin Impurity 30 |
1395056-42-4 |
C21H24FN3O7 |
 |
Tenofovir Impurity 37 |
161760-03-8 |
C10H15O6PS |
 |
Apremilast |
1384967-20-7 |
C20H20N2O7S |
 |
Pramipexole Impurity 30 |
1802051-36-0 |
C13H24ClN3S |
 |
NZWJKTHFNLHUJO-NWZSJJIMSA-N |
1422954-12-8 |
C22H26FN3O5S |
 |
LAT-NET |
607351-44-0 |
C25H39NO4 |
 |
N,N-(ethane-1,2-diyl)bis(4-methyl-N-(3-((4-methylphenyl)sulfonamido)propyl)benzenesulfonamide) |
74676-47-4 |
C36H46N4O8S4 |
 |
L-GLUCONO-1,5-LACTONE |
52153-09-0 |
C6H10O6 |
 |
C-Desmethyl Atenolol |
1797116-92-7 |
C13H20N2O3 |
 |
Losartan Impurity 7 |
358685-13-9 |
C33H24Br2N4 |
 |
Fenofibric Acid 1-Carboxyl-1-methylethyl Ester |
1797121-54-0 |
C21H21ClO6 |
 |
2-Chloro-4'-fluorobenzophenone |
1806-23-1 |
C13H8ClFO |
 |
Ambrisentan Impurity E |
1312092-82-2 |
C21H18N2O3 |